Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
PCV21 Mixed Schedules in Healthy Infants and Toddlers
NCT06824181Phase 3Active, not recruiting
- Sponsor
- Sanofi
- Start
- Feb 2025
- Primary completion
- Sep 2027
- Modality
- Vaccines & Immunotherapeutics
- Countries
- 4
01
Overview
A Phase 3 trial of PCV21 in pneumococcal infection, sponsored by Sanofi. Started Feb 2025; status: active, not recruiting.
02
Drugs
PCV21
03
Conditions
pneumococcal infection
Beyond the preview
Go deeper on NCT06824181.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06824181.